Market Cap : 2.63 B | Enterprise Value : 2.19 B | PE Ratio : 26.38 | PB Ratio : 5.02 |
---|
NAS:CORT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CORT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Corcept Therapeutics's inventories, raw materials & components for the quarter that ended in Dec. 2020 was $1.7 Mil.
Corcept Therapeutics's quarterly raw materials increased from Jun. 2020 ($0.0 Mil) to Sep. 2020 ($1.5 Mil) and increased from Sep. 2020 ($1.5 Mil) to Dec. 2020 ($1.7 Mil).
Corcept Therapeutics's annual raw materials increased from Dec. 2018 ($0.0 Mil) to Dec. 2019 ($1.4 Mil) and increased from Dec. 2019 ($1.4 Mil) to Dec. 2020 ($1.7 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
Materials and components scheduled for use in making a product.
No Headline